The Food Safety and Standards Act, 2006 (the Act) governs a wide array of activities in relation to food products and its ingredients including manufacturing, importing, processing, packaging, wholesa...
Over the past couple of months, regulatory authorities in the healthcare and pharmaceutical sectors have been highly active in the enforcement of good manufacturing practices amid drug quality concerns across India. In addition, the formulation of guidelines for regulating commercial usage of de-identified biological samples, the landmark injunction order issued by the Delhi High Court against Zydus’ product ‘Sigrima’, and the lack of emphasis placed by the Union Budget on the healthcare industry dominated headlines in the space.
Against this backdrop, INDUSLAW's Shantanu Jindel, Shweta Gupta, Harshit Kumar, Vatsal Agarwal, and Abhinav present you this edition of 'Checking the Pulse', delving into key updates from June 2024 to July 2024 in the healthcare and pharmaceutical sectors, while also tapping on notable deals that have gained interest from the industry.
